Watch as I experiment with making takedown recurve bow limbs. Mild steel didn’t work, but repurposing old skis created a ...

When it’s time for Wisconsin bowhunters to launch an arrow, their tool of choice matters little to individual deer, a ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...